Which Marijuana Stock Is a Top Buy This Summer?

Canopy Growth Corp. (TSX:WEED) is among the top three marijuana producers that are well positioned to benefit from Canada’s pot legalization this summer.

| More on:

As the legalization deadline for marijuana recreational use nears, some investors are again looking toward Canada’s pot stocks, hoping to make a quick buck. But does investing in marijuana stocks make sense just before this major event?

By looking at the share prices of Canada’s top marijuana producers, it seems the majority of investors have adopted a wait-and-see approach. After delivering triple-digit gains in 2017, the top marijuana stocks are having a roller-coaster ride so far this year.

This price action partly reflects the impact of the ongoing consolidation in the sector, and it’s partly due to the nervousness of investors about the supply/demand scenario once recreational use is legalized in Canada this summer. Let’s have a look at the big pot stocks and their performance to better understand the risk/reward equation.

Canopy Growth Corp. (TSX:WEED) is ideally positioned to take advantage of the enormous potential of this market. Alcoholic beverage giant Constellation Brands is one of the investors in this company with a 9.9% stake.

What makes Canopy different from other producers is its market size, capacity to ramp up production, the diversification of its product offerings, and international reach. In the most recent quarterly earnings report, Canopy’s sales more than doubled in the third quarter compared with a year ago, fueled by a significant jump in domestic sales as well as sales in the German medical market.

This spring, Canopy won a cultivation licence in British Columbia — the first of its two sites operating under the BC Tweed Joint Venture Inc. The licensing approval of the Aldergrove site, the largest federally licensed cannabis site in the world, covers over 400,000 sq. ft. of space.

Trading at $36.90 at the time of writing, Canopy stock is up 14% this year after a tumultuous start to the year. At this price, the majority of analysts see Canopy trading close to its fair value.

Aurora Cannabis Inc. (TSX:ACBstock has failed to create excitement for investors in 2018, despite its two mega deals in its bid to becoming the largest marijuana producer.

After surging more than 300% in 2017, its stock is down 37% this year, following its acquisitions of CanniMed Therapeutics Inc. and then MedReleaf Corp. for $3.2 billion — the biggest deal in the fast-consolidating marijuana sector ahead of the legalization.

Aurora and MedReleaf together expect to produce over 570,000 kilograms of cannabis per year through nine facilities in Canada and two in Denmark.

These transactions, however, didn’t get a favourable reception from the market, as many analysts viewed them as dilutive for existing shareholders. Paying such a high valuation also didn’t make sense when marijuana companies’ share prices started to deflate this year. That said, Aurora remains the fastest-growing cannabis producer and is well positioned to take advantage of the recreational opportunity.

Aphria Inc.’s (TSX:APH) stock performance has also been disappointing this year. Its shares have been under pressure since the company announced the Nuuvera acquisition this January in exchange for a combination of cash and Aphria stock. Investors didn’t like the deal, in which Aphria issued new shares, diluting existing shareholders.

On the fundamental side, however, Aphria is doing just fine. The company made record sales in the third, as its sales volumes more than doubled.

The company’s acquisitions of Nuuvera and Broken Coast Cannabis earlier this year have positioned Aphria as a major player in both Canada and abroad. Aphria’s Nuuvera acquisition gives the company exposure to many global markets, including Germany.

The bottom line

Investing in marijuana stocks in 2018 has become a risky bet after such a massive rally last year in a build-up to the legalization stage. From here, investors’ focus has shifted to the actual performance of these companies once the recreational market opens for business. If you’re a risk taker and you want to have some exposure to this volatile segment of the market, then I would advise you stick with these big names. I like both Canopy and Aurora.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Haris Anwar has no position in any stocks mentioned.

More on Investing

gas station, convenience store, gas pumps
Investing

Where Will Couche-Tard Stock Be in 5 Years?

Alimentation Couche-Tard (TSX:ATD) stock looks dirt-cheap after its latest pullback for TFSA investors looking to grow wealth over the next…

Read more »

Index funds
Investing

Top 3 S&P 500 Index Funds

Here are my top three picks when it comes to investing in the S&P 500 for Canadians.

Read more »

calculate and analyze stock
Dividend Stocks

The 5 Best Low-Risk Investments for Canadians

If you're wanting to keep things low risk in this volatile market, these are the top five places where investors…

Read more »

Payday ringed on a calendar
Dividend Stocks

How to Build a Bulletproof Monthly Passive-Income Portfolio in 2024 With Just $25,000

Invest in quality monthly dividend ETFs such as the XDIV to create a recurring and reliable passive-income stream for life.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, April 19

The main TSX index seems on track to post another losing week as it currently trades with 0.9% week-to-date losses.

Read more »

Dollar symbol and Canadian flag on keyboard
Dividend Stocks

The CRA Benefits Every Canadian Will Want to Maximize in 2024

Canadian taxpayers can lighten their tax burdens in 2024 through three CRA benefits and the prompt filing of tax returns.

Read more »

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Woman has an idea
Investing

3 No-Brainer Stocks to Buy With $200 Right Now

These three stocks are no-brainer buys, given their solid underlying businesses and healthy growth prospects.

Read more »